↓ Skip to main content

Inhibition of monoamine oxidase-B by the polyphenolic compound, curcumin and its metabolite tetrahydrocurcumin, in a model of Parkinson’s disease induced by MPTP neurodegeneration in mice

Overview of attention for article published in Inflammopharmacology, April 2008
Altmetric Badge

About this Attention Score

  • In the top 25% of all research outputs scored by Altmetric
  • High Attention Score compared to outputs of the same age (89th percentile)

Mentioned by

blogs
1 blog
twitter
1 X user
patent
12 patents
reddit
1 Redditor

Citations

dimensions_citation
147 Dimensions

Readers on

mendeley
96 Mendeley
Title
Inhibition of monoamine oxidase-B by the polyphenolic compound, curcumin and its metabolite tetrahydrocurcumin, in a model of Parkinson’s disease induced by MPTP neurodegeneration in mice
Published in
Inflammopharmacology, April 2008
DOI 10.1007/s10787-007-1614-0
Pubmed ID
Authors

A. Rajeswari, M. Sabesan

X Demographics

X Demographics

The data shown below were collected from the profile of 1 X user who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 96 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Belgium 1 1%
Unknown 95 99%

Demographic breakdown

Readers by professional status Count As %
Student > Ph. D. Student 21 22%
Student > Master 16 17%
Student > Bachelor 11 11%
Student > Doctoral Student 9 9%
Researcher 8 8%
Other 11 11%
Unknown 20 21%
Readers by discipline Count As %
Agricultural and Biological Sciences 20 21%
Pharmacology, Toxicology and Pharmaceutical Science 12 13%
Biochemistry, Genetics and Molecular Biology 10 10%
Medicine and Dentistry 10 10%
Neuroscience 9 9%
Other 10 10%
Unknown 25 26%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 11. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 07 November 2023.
All research outputs
#3,223,308
of 25,307,332 outputs
Outputs from Inflammopharmacology
#86
of 669 outputs
Outputs of similar age
#9,582
of 92,104 outputs
Outputs of similar age from Inflammopharmacology
#2
of 2 outputs
Altmetric has tracked 25,307,332 research outputs across all sources so far. Compared to these this one has done well and is in the 87th percentile: it's in the top 25% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 669 research outputs from this source. They typically receive more attention than average, with a mean Attention Score of 9.4. This one has done well, scoring higher than 87% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 92,104 tracked outputs that were published within six weeks on either side of this one in any source. This one has done well, scoring higher than 89% of its contemporaries.
We're also able to compare this research output to 2 others from the same source and published within six weeks on either side of this one.